ATE412738T1 - Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen - Google Patents

Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Info

Publication number
ATE412738T1
ATE412738T1 AT00420113T AT00420113T ATE412738T1 AT E412738 T1 ATE412738 T1 AT E412738T1 AT 00420113 T AT00420113 T AT 00420113T AT 00420113 T AT00420113 T AT 00420113T AT E412738 T1 ATE412738 T1 AT E412738T1
Authority
AT
Austria
Prior art keywords
strains
denguevirus
attenuate
vaccine compositions
serotype
Prior art date
Application number
AT00420113T
Other languages
English (en)
Inventor
Nath Bhamarapravat
Sutee Yoksan
Original Assignee
Univ Mahidol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mahidol filed Critical Univ Mahidol
Application granted granted Critical
Publication of ATE412738T1 publication Critical patent/ATE412738T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00420113T 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen ATE412738T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00420113A EP1159968B1 (de) 2000-05-30 2000-05-30 Attenuierte Stammen von Denguevirus und ihre Verwendungen in Impfstoffzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE412738T1 true ATE412738T1 (de) 2008-11-15

Family

ID=8174060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00420113T ATE412738T1 (de) 2000-05-30 2000-05-30 Attenuierte stammen von denguevirus und ihre verwendungen in impfstoffzusammensetzungen

Country Status (7)

Country Link
EP (1) EP1159968B1 (de)
AT (1) ATE412738T1 (de)
CY (1) CY1108666T1 (de)
DE (1) DE60040652D1 (de)
DK (1) DK1159968T3 (de)
ES (1) ES2315221T3 (de)
PT (1) PT1159968E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2611954C (en) * 2005-06-17 2014-01-28 Sanofi Pasteur Dengue serotype 2 attenuated strain
CN101238144B (zh) * 2005-06-17 2012-09-05 赛诺菲巴斯德有限公司 登革血清型1减毒株
US7968102B2 (en) * 2006-01-13 2011-06-28 Sanofi Pasteur S.A. Dengue chimeric viruses
AR061197A1 (es) * 2006-06-07 2008-08-13 Sanofi Pasteur Cepas del virus 3 del dengue vivas atenuadas
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
CN101959527B (zh) 2008-03-05 2016-04-20 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
EP2143440A1 (de) 2008-07-09 2010-01-13 Sanofi Pasteur Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
EP2353609A1 (de) 2010-02-04 2011-08-10 Sanofi Pasteur Immunisierungszusammensetzungen und -verfahren
SG10201912291YA (en) 2012-07-24 2020-02-27 Sanofi Pasteur Vaccine compositions
AU2013295016A1 (en) 2012-07-24 2015-01-29 Sanofi Pasteur Vaccine compositions for prevention against dengue virus infection
BR112015012515B1 (pt) 2012-11-30 2023-04-11 Sanofi Pasteur Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola
EP2968516B1 (de) * 2013-03-15 2022-01-12 Takeda Vaccines, Inc. Zusammensetzungen und verfahren für chimäre dengue-viruskonstrukte in impfstoffen
KR102373570B1 (ko) * 2015-11-27 2022-03-10 케이엠 바이올로직스 가부시키가이샤 뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
WO2019069130A1 (en) 2017-10-05 2019-04-11 Sanofi Pasteur COMPOSITIONS FOR RECALL VACCINATION AGAINST DENGUE
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040933A1 (en) * 1995-06-07 1996-12-19 The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Also Published As

Publication number Publication date
ES2315221T3 (es) 2009-04-01
PT1159968E (pt) 2008-11-20
DE60040652D1 (de) 2008-12-11
CY1108666T1 (el) 2014-04-09
DK1159968T3 (da) 2009-02-23
EP1159968B1 (de) 2008-10-29
EP1159968A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
CY1108666T1 (el) Εξασθενημενα στελεχη του δαγγειου πυρετου και η χρηση τους σε μια συνθεση εμβολιου
EA200300023A1 (ru) 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
CR6540A (es) Trifluorobutenos nematicidas
DE60130987D1 (de) Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
DK1377593T3 (da) 2-Amino-propanolderivater
EP1399163A4 (de) Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv)
DE69031560D1 (de) Verfahren und zusammensetzungen zum stimulieren von vesikulär-arbuskulären mykorrhizapilzen
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
NO20026044L (no) Behandling av humant papillomavirus
NO955047L (no) Sekundære aminer som antidiabetiske og antifedme-midler
DE60114865D1 (de) Heterologe herstellung von polyketiden
NO20004978L (no) Semi-syntetiske ecteinascidiner
WO2001007027A3 (en) Pyrimidine derivatives for the treatment of viral diseases
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
ATE144498T1 (de) Herstellung von substituierten piperidinen
DK1089625T3 (da) Ektoparasiticide midler
ATE255105T1 (de) Serotonerge benzofurane
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
ATE223893T1 (de) Naphthopyranderivate, zubereitungen und dieselben enthaltende (co)polymermatrizen
DE59006541D1 (de) Mittel zum Schutz von Pflanzen gegen Krankheiten.
DK0660822T3 (da) Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler
ATE401388T1 (de) Protomikroemulsion, diese enthaltendes reinigungsgerät und verwendung von diesen
ATE235450T1 (de) 2-indanmethanolderivate und ihre verwendung als riechstoffe
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159968

Country of ref document: EP